Deal Capsule

Deal Capsule

Transactions in Chemicals & Pharmaceuticals

Transactions in Chemicals & Pharmaceuticals

M&A continues to be brisk with the number of completed deals in Q1-Q3 2016 remaining at a high level in both sectors. While the pharmaceutical total deal value decreased almost 40% in Q1-Q3 2016 versus Q1-Q3 2015, chemicals saw a 60% increase.

 

Connect with us

KPMG's new digital platform

KPMG's new digital platform

Deal Capsule - Transactions in Pharmaceuticals October 2016

Pharmaceutical deal activity was strongly impacted by Teva closing the $40.5 billion acquisition of Allergan’s generics business.

 
Read more

Deal Capsule - Transactions in Chemicals October 2016

Monsanto agreed to Bayer’s $66 billion acquisition offer. Consolidation in the agrochemicals and fertilizer market continues.

 
Read more